Physician

Brian Christopher Reed, MD

According to 2025 Medicare claims, Brian Reed, MD (NPI: 1538432190) practices allergy/immunology in the Pensacola-Ferry Pass-Brent, FL market, with the plurality of this provider's patient population coming from Escambia, FL. This provider's primary affiliated billing organization is PREMIER ALLERGIST OF FLORIDA LLC (NPI: 1427237486; TIN: 591858789) and primary practice location at 32514-6067. Reed is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Reed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 257 traditional Medicare patients, billed 14,849 HCPCS/CPT codes, and received $202,997 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 251 prescription claims across 92 beneficiaries totaling $92,693 in drug costs, led by Dupixent Pen (Dupilumab). 2023 DME data shows 104 claims. Open Payments data shows 146 records totaling $3,093. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $75,725 and ending at $202,997. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $42,422 to $92,693. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,683 and ending at $3,537.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$268K$537K2015 Medicare payment: $75,725 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $97,499 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $47,619 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $51,472 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $349,401 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $536,561 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $405,949 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $201,049 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $202,997 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153921,002$75,725
20165041,261$97,499
2017250565$47,619
2018N/RN/RN/R
2019842,742$51,472
202032515,836$349,401
202131722,040$536,561
202225115,763$405,949
20232628,904$201,049
202425714,849$202,997

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$699K$1.4M2015 Drug cost: $42,422 (USD; Tot_Drug_Cst)2016 Drug cost: $34,086 (USD; Tot_Drug_Cst)2017 Drug cost: $16,852 (USD; Tot_Drug_Cst)2018 Drug cost: $10,845 (USD; Tot_Drug_Cst)2019 Drug cost: $42,167 (USD; Tot_Drug_Cst)2020 Drug cost: $169,313 (USD; Tot_Drug_Cst)2021 Drug cost: $224,988 (USD; Tot_Drug_Cst)2022 Drug cost: $1,398,965 (USD; Tot_Drug_Cst)2023 Drug cost: $775,673 (USD; Tot_Drug_Cst)2024 Drug cost: $92,693 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015203606$42,422
2016144412$34,086
2017102242$16,852
20182868$10,845
201977254$42,167
2020154619$169,313
2021144627$224,988
2022172795$1,398,965
2023149634$775,673
202492251$92,693

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$91K$181K2015 Medicare payment: $3,857 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $5,775 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,326 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $59,299 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $122,784 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $181,167 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $141,362 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R55$3,857
201611116$5,775
2017N/R36$1,326
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R68$59,299
2021N/R108$122,784
2022N/R125$181,167
2023N/R104$141,362
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more8484$127
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5470$93
94060Test to measure expiratory airflow and volume changes before and after medication administration6988$29
95165Professional service for preparation and provision of 1 or more antigens851,272$11
95004Test for allergy using allergenic extract916,128$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab11308$41,163
Spiriva RespimatTiotropium Bromide15510$8,543
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13390$7,952
Breztri AerosphereBudesonide/Glycopyr/Formoterol11330$6,588
Breo ElliptaFluticasone/Vilanterol12360$4,617

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.146$3,093AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brian Christopher Reed, MD?

Tedicare shows public-source Medicare data for Brian Christopher Reed, MD (NPI 1538432190), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Christopher Reed, MD have ACO affiliation data?

Brian Christopher Reed, MD is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Brian Christopher Reed, MD?

Brian Christopher Reed, MD is linked to PREMIER ALLERGIST OF FLORIDA LLC (billing NPI 1427237486) in the available physician profile data.

Does Brian Christopher Reed, MD have Open Payments data?

Brian Christopher Reed, MD has 146 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.